DUBLIN, April 8, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Liquid Biopsy Markets - Global Market Size, Strategies and Forecasts 2016 to 2020 including Screening Market Sizing" report to their offering.
This comprehensive report analyzes the global liquid biopsy market and the key topics all market participants should be aware of. It considers current and future drivers, challenges and opportunities, providing an unrivalled understanding of the market.
A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.
Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.
Companies Mentioned Include:
- AdnaGen (now Qiagen)
- Agena Bioscience
- Angle plc
- ApoCell
- Biocept
- BioFluidica
- Bio-Rad Laboratories
- Boreal Genomics
- Chronix Biomedical
- Clearbridge BioMedics
- Cynvenio
- Janssen Diagnostics
- Molecular MD
- Myriad Genetics
- Natera
- New Oncology
- Personal Genome Diagnostics
- RainDance Technologies
- Rarecells SAS
- Silicon Biosystems
- Sysmex Inostics
- SRI International
- Trovagene
Report Structure:
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Liquid Biopsy Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
10. Potential Market Opportunity Sizes
Appendices
For more information visit http://www.researchandmarkets.com/research/zpfwj7/liquid_biopsy
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article